<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04375826</url>
  </required_header>
  <id_info>
    <org_study_id>2003-128-111</org_study_id>
    <nct_id>NCT04375826</nct_id>
  </id_info>
  <brief_title>Preperitoneal Analgesia Versus Epidural Analgesia After Open Pancreaticoduodenectomy</brief_title>
  <acronym>Pain</acronym>
  <official_title>Continuous Preperitoneal Analgesia Versus Thoracic Epidural Analgesia After Open Pancreaticoduodenectomy: A Randomized Controlled Open-labeled Noninferiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized open-label noninferiority trial that compares thoracic&#xD;
      epidural analgesia and continuous preperitoneal analgesia after open pancreaticoduodenectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the Enhanced recovery after surgery (ERAS) program of pancreaticoduodenectomy (PD),&#xD;
      thoracic epidural analgesia (or epidural analgesia) was considered to be a key analgesic&#xD;
      method because it not only effectively controls pain, but also lowers insulin resistance and&#xD;
      helps restore bowel movement. However, epidural analgesia can cause a number of side effects&#xD;
      despite of effective pain control. Epidural analgesia reduces peripheral vascular resistance&#xD;
      by blocking sympathetic nerves with local anesthetics and may cause hypotension and&#xD;
      decreasing heart rate. In addition, it can cause orthostatic hypotension, which can interfere&#xD;
      with early ambulation after operation. In rare cases, there are potential complications of&#xD;
      epidural abscess, meningitis, and epidural hematoma.&#xD;
&#xD;
      Continuous peritoneal analgesia using local anesthetics has recently been used as an&#xD;
      alternative analgesic to epidural analgesia in open abdomen surgery. This is easier to&#xD;
      perform than epidural analgesia and is known to have fewer side effects. Recently, a&#xD;
      non-inferiority comparison study have revealed that peritoneal analgesic was not inferior to&#xD;
      epidural analgesia in terms of pain control. However, this study included a variety of&#xD;
      operations other than PD, and most of the incisions were substernal, not midline. In&#xD;
      addition, the method for mounting the epidural catheter was not described. The failure rate&#xD;
      of the epidural catheter was reported to be 15%.&#xD;
&#xD;
      The investigators will examine the effect of continuous peritoneal analgesic postoperative&#xD;
      pain control in patients undergoing open PD to improve postoperative pain management and to&#xD;
      create an our own ERAS program. To this end, The investigators will test non-inferiority&#xD;
      between epidural analgesia and peritoneal analgesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 13, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical rating score for pain at 24 hours after operation</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>The scale of the numerical rating score for pain is 0~10 and higher score is worse outcome.&#xD;
At 24 hours after operation, NRS pain scores are compared between two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain related factors</measure>
    <time_frame>postoperative day 1,2,and 3</time_frame>
    <description>The scale of the numerical rating score for pain is 0~10 and higher score is worse outcome.&#xD;
Numerical rating score for pain on postoperative day 2 and 3 at 4pm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall benefit of analgesia score (OBAS)</measure>
    <time_frame>postoperative day 1,2,and 3</time_frame>
    <description>OBAS on postoperative day 1,2,and 3. This include 7 questions. To calculate the OBAS score, compute the sume of scores in items 1~6 and add &quot;4-socore in item 7&quot;. The minimum score is 4 and the maximum is 24.The low score indicates high benefit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery related factors</measure>
    <time_frame>Within 1 week after operation</time_frame>
    <description>Time to first eat meal, time to first move, time to first gas out</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complication factors</measure>
    <time_frame>Within 1 week after operation</time_frame>
    <description>Clavien-Dindo classification, postoperative pancreatic fistula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesic related factors</measure>
    <time_frame>Within 2 week after operation</time_frame>
    <description>rescue analgesics amounts, opioid amounts</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Pain Management</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Epidural analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Only Epidural analgesia is used for this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preperitoneal analgesia and IV-PCA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group is given with both preperitoneal analgesia and Intravenous Patient Controlled Analgesia (IV-PCA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural patient controlled analgesia</intervention_name>
    <description>The device is connected to the epidural catheter prior to surgery and drug administration is started during surgery. The continuous infusion rate is 4 ml / hr. When the button is pressed, 2 ml is additionally administered and the lock time is 20 minutes.</description>
    <arm_group_label>Epidural analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Preperitoneal analgesia and IV-PCA</intervention_name>
    <description>During surgery, the preperitoneal analgesia catheters are inserted into the preperitoneal space and these catheters are connected to the pump with ropivacaine.</description>
    <arm_group_label>Preperitoneal analgesia and IV-PCA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years and older&#xD;
&#xD;
          -  Disease of periampullary lesions&#xD;
&#xD;
          -  Elective open pancreaticoduodenectomy (PD): PD or pylorus preserving&#xD;
             pancreaticoduodenectomy (PPPD)&#xD;
&#xD;
          -  Midline incision&#xD;
&#xD;
          -  Written informed consent : ability to understand and the willingness to sign a written&#xD;
             informed consent&#xD;
&#xD;
          -  Performance status (ECOG scale): 0-1 at the time of enrollment&#xD;
&#xD;
          -  Physical status (ASA) : 1-2 grade&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of neoadjuvant chemotherapy&#xD;
&#xD;
          -  History of any abdominal surgery (except laparoscopic appendectomy,&#xD;
             laparoscopic/robotic cholecystectomy, laparoscopic/robotic obstetrics and gynecology&#xD;
             surgeries,Cesarean section, laparoscopic/robotic prostate surgery)&#xD;
&#xD;
          -  Emergency operation&#xD;
&#xD;
          -  History of chronic pain&#xD;
&#xD;
          -  Chronic use of opioid, analgesics, anti-depressant, anti-epileptics (&gt;1year)&#xD;
&#xD;
          -  Alcoholics&#xD;
&#xD;
          -  Impossible to control PCA d/t delirium, cognitive impairment&#xD;
&#xD;
          -  Contraindication for epidural analgesia&#xD;
&#xD;
          -  Patients with coagulopathy (INR&gt;1.5, Prothrombin time&gt;1.5, platelets &lt;80x10^9perL) or&#xD;
             anti-coagulants&#xD;
&#xD;
          -  Hypersensitive to fentanyl and ropivacaine&#xD;
&#xD;
          -  Need other organ resection (ex. Liver, colon)&#xD;
&#xD;
          -  Intubation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Young Jang, M.D., PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-Young Jang, M.D., PhD.</last_name>
    <phone>82-2-2072-2194</phone>
    <email>jangjy4@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yoo Jin Choi, M.D.</last_name>
    <phone>82-2-2072-1959</phone>
    <email>ujinny30@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Surgery, Seoul National University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin- Young Jang, M.D., PhD.</last_name>
      <phone>82-2-2072-2194</phone>
      <email>jangjy4@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Wooil Kwon, M.D., PhD.</last_name>
      <phone>82-2-2072-2817</phone>
      <email>willdoc78@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jin- Young Jang, M.D., PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wooil Kwon, M.D., PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hongbeom Kim, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 26, 2020</study_first_submitted>
  <study_first_submitted_qc>May 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2020</study_first_posted>
  <last_update_submitted>January 16, 2021</last_update_submitted>
  <last_update_submitted_qc>January 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Young Jang</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Pain management</keyword>
  <keyword>Postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

